<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35466006</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-108X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>45</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Trends in neurosciences</Title>
          <ISOAbbreviation>Trends Neurosci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Circadian clock, diurnal glucose metabolic rhythm, and dawn phenomenon.</ArticleTitle>
        <Pagination>
          <StartPage>471</StartPage>
          <EndPage>482</EndPage>
          <MedlinePgn>471-482</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tins.2022.03.010</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0166-2236(22)00061-3</ELocationID>
        <Abstract>
          <AbstractText>The circadian clock provides cue-independent anticipatory signals for diurnal rhythms of baseline glucose levels and glucose tolerance. The central circadian clock is located in the hypothalamic suprachiasmatic nucleus (SCN), which comprises primarily GABAergic neurons. The SCN clock regulates physiological diurnal rhythms of endogenous glucose production (EGP) and hepatic insulin sensitivity through neurohumoral mechanisms. Disruption of the molecular circadian clock is associated with the extended dawn phenomenon (DP) in type 2 diabetes (T2D), referring to hyperglycemia in the early morning without nocturnal hypoglycemia. The DP affects nearly half of patients with diabetes, with poorly defined etiology and a lack of targeted therapy. Here we review neural and secreted factors in physiological diurnal rhythms of glucose metabolism and their pathological implications for the DP.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Elsevier Ltd. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Peng</LastName>
            <ForeName>Fei</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Baylor College of Medicine, Houston, TX, USA; State Key Laboratory of Zoonotic Diseases, The First Hospital of Jilin University, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Xin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiao</LastName>
            <ForeName>Fang</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Baylor College of Medicine, Houston, TX, USA; Department of Cadres Medical Care and Geriatrics, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Ruxing</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Zheng</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Baylor College of Medicine, Houston, TX, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA. Electronic address: zheng.sun@bcm.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>P30 ES030285</GrantID>
            <Acronym>ES</Acronym>
            <Agency>NIEHS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 ES027544</GrantID>
            <Acronym>ES</Acronym>
            <Agency>NIEHS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Trends Neurosci</MedlineTA>
        <NlmUniqueID>7808616</NlmUniqueID>
        <ISSNLinking>0166-2236</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>IY9XDZ35W2</RegistryNumber>
          <NameOfSubstance UI="D005947">Glucose</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D057906" MajorTopicYN="Y">Circadian Clocks</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002940" MajorTopicYN="N">Circadian Rhythm</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006943" MajorTopicYN="Y">Hyperglycemia</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013493" MajorTopicYN="N">Suprachiasmatic Nucleus</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">GABA</Keyword>
        <Keyword MajorTopicYN="N">SCN</Keyword>
        <Keyword MajorTopicYN="N">circadian rhythm</Keyword>
        <Keyword MajorTopicYN="N">diabetes</Keyword>
        <Keyword MajorTopicYN="N">metabolism</Keyword>
        <Keyword MajorTopicYN="N">neuron</Keyword>
      </KeywordList>
      <CoiStatement>Declaration of interests The authors declare no interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>6</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>25</Day>
          <Hour>5</Hour>
          <Minute>57</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35466006</ArticleId>
        <ArticleId IdType="mid">NIHMS1794598</ArticleId>
        <ArticleId IdType="pmc">PMC9117496</ArticleId>
        <ArticleId IdType="doi">10.1016/j.tins.2022.03.010</ArticleId>
        <ArticleId IdType="pii">S0166-2236(22)00061-3</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Takahashi JS (2017) Transcriptional architecture of the mammalian circadian clock. Nat. Rev. Genet
18, 164–179</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5501165</ArticleId>
            <ArticleId IdType="pubmed">27990019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patke A
et al. (2020) Molecular mechanisms and physiological importance of circadian rhythms. Nat. Rev. Mol. Cell Biol
21, 67–84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31768006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hastings MH
et al. (2018) Generation of circadian rhythms in the suprachiasmatic nucleus. Nat. Rev. Neurosci
19, 453–469</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29934559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colwell CS (2011) Linking neural activity and molecular oscillations in the SCN. Nat. Rev. Neurosci
12, 553–569</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4356239</ArticleId>
            <ArticleId IdType="pubmed">21886186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morin LP (2013) Neuroanatomy of the extended circadian rhythm system. Exp. Neurol
243, 4–20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3498572</ArticleId>
            <ArticleId IdType="pubmed">22766204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buijs RM (2013) The autonomic nervous system: a balancing act. Handb. Clin. Neurol
117, 1–11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24095111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okamura H (2007) Suprachiasmatic nucleus clock time in the mammalian circadian system. Cold Spring Harb. Symp. Quant. Biol
72, 551–556</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18419314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flaa A
et al. (2008) Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. Metabolism. 57, 1422–1427</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18803948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chazova I
et al. (2006) Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin. Diabetes Obes. Metab
8, 456–465</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16776753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klieverik LP
et al. (2008) Effects of thyrotoxicosis and selective hepatic autonomic denervation on hepatic glucose metabolism in rats. Am. J. Physiol. Endocrinol. Metab
294, E513–520</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18182466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smale L
et al. (2003) Mammalian diurnality: some facts and gaps. J. Biol. Rhythms
18, 356–366</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14582852</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmidt MI
et al. (1981) The dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variation. Diabetes Care
4, 579–585</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6751733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monnier L
et al. (2013) Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern?
Diabetes Care
36, 4057–4062</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3836163</ArticleId>
            <ArticleId IdType="pubmed">24170753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Neal TB and Luther EE (2020) Dawn Phenomenon. In StatPearls
StatPearls Publishing</Citation>
        </Reference>
        <Reference>
          <Citation>Porcellati F
et al. (2013) Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes. Diabetes Care
36, 3860–3862</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3836156</ArticleId>
            <ArticleId IdType="pubmed">24265365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li C
et al. (2020) The dawn phenomenon across the glycemic continuum: Implications for defining dysglycemia. Diabetes Res. Clin. Pract
166, 108308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32650035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carroll MF and Schade DS (2005) The dawn phenomenon revisited: implications for diabetes therapy. Endocr. Pract. Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol
11, 55–64</Citation>
        </Reference>
        <Reference>
          <Citation>Boden G
et al. (1996) Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production. Diabetes
45, 1044–1050</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8690150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Feo P
et al. (1986) Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon. Diabetologia
29, 475–480</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3530862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perriello G
et al. (1997) Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes
46, 1010–1016</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9166673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radziuk J and Pye S (2006) Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour?
Diabetologia
49, 1619–1628</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16752180</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding G
et al. (2021) REV-ERB in GABAergic neurons controls diurnal hepatic insulin sensitivity. Nature
592, 763–767</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8085086</ArticleId>
            <ArticleId IdType="pubmed">33762728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang Y
et al. (2017) Poor Sleep Quality Is Associated with Dawn Phenomenon and Impaired Circadian Clock Gene Expression in Subjects with Type 2 Diabetes Mellitus. Int. J. Endocrinol
2017, 4578973.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5352967</ArticleId>
            <ArticleId IdType="pubmed">28352282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren H
et al. (2015) [Association between sleep disorders and dawn phenomenon in patients with type 2 diabetes mellitus]. Zhonghua Yi Xue Za Zhi
95, 1209–1213</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26081502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chamorro R
et al. (2021) Acute mild dim light at night slightly modifies sleep but does not affect glucose homeostasis in healthy men. Sleep Med. 84, 158–164</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34153798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mokhlesi B
et al. (2017) Effect of one week of CPAP treatment of obstructive sleep apnoea on 24-hour profiles of glucose, insulin and counter-regulatory hormones in type 2 diabetes. Diabetes Obes. Metab
19, 452–456</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27860160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paing AC
et al. (2020) Diurnal patterns of objectively measured sedentary time and interruptions to sedentary time are associated with glycaemic indices in type 2 diabetes. J. Sci. Med. Sport
23, 1074–1079</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32646745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paing AC
et al. (2019) Dose-response between frequency of interruption of sedentary time and fasting glucose, the dawn phenomenon and night-time glucose in Type 2 diabetes. Diabet. Med. J. Br. Diabet. Assoc
36, 376–382</Citation>
        </Reference>
        <Reference>
          <Citation>Zheng X
et al. (2020) Effects of Exercise on Blood Glucose and Glycemic Variability in Type 2 Diabetic Patients with Dawn Phenomenon. BioMed Res. Int
2020, 6408724.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7057022</ArticleId>
            <ArticleId IdType="pubmed">32149118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalsbeek A
et al. (2014) Circadian control of glucose metabolism. Mol. Metab
3, 372–383</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4060304</ArticleId>
            <ArticleId IdType="pubmed">24944897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>La Fleur SE (2003) Daily rhythms in glucose metabolism: suprachiasmatic nucleus output to peripheral tissue. J. Neuroendocrinol
15, 315–322</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12588521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Cauter E
et al. (1997) Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr. Rev
18, 716–738</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9331550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>La Fleur SE
et al. (1999) A suprachiasmatic nucleus generated rhythm in basal glucose concentrations. J. Neuroendocrinol
11, 643–652</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10447803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Challet E
et al. (2004) Daily variations of blood glucose, acid-base state and PCO2 in rats: effect of light exposure. Neurosci. Lett
355, 131–135</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14729252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cailotto C
et al. (2005) The suprachiasmatic nucleus controls the daily variation of plasma glucose via the autonomic output to the liver: are the clock genes involved?
Eur. J. Neurosci
22, 2531–2540</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16307595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalsbeek A and Strubbe JH (1998) Circadian control of insulin secretion is independent of the temporal distribution of feeding. Physiol. Behav
63, 553–558</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9523898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bolli GB
et al. (1984) Demonstration of a dawn phenomenon in normal human volunteers. Diabetes
33, 1150–1153</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6389230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takeda Y
et al. (2014) Retinoic acid-related orphan receptor γ (RORγ): a novel participant in the diurnal regulation of hepatic gluconeogenesis and insulin sensitivity. PLoS Genet. 10, e1004331.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4022472</ArticleId>
            <ArticleId IdType="pubmed">24831725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iwayama K
et al. (2020) Diurnal variation in the glycogen content of the human liver using 13 C MRS. NMR Biomed. 33, e4289.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32157774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakagawa H and Okumura N (2010) Coordinated regulation of circadian rhythms and homeostasis by the suprachiasmatic nucleus. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci
86, 391–409</Citation>
        </Reference>
        <Reference>
          <Citation>Foppen E
et al. (2016) Suprachiasmatic Nucleus Neuropeptides and Their Control of Endogenous Glucose Production. J. Neuroendocrinol
28,</Citation>
        </Reference>
        <Reference>
          <Citation>Kalsbeek A
et al. (2004) Suprachiasmatic GABAergic inputs to the paraventricular nucleus control plasma glucose concentrations in the rat via sympathetic innervation of the liver. J. Neurosci. Off. J. Soc. Neurosci
24, 7604–7613</Citation>
        </Reference>
        <Reference>
          <Citation>Kalsbeek A
et al. (2008) Circadian control of the daily plasma glucose rhythm: an interplay of GABA and glutamate. PloS One
3, e3194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2527681</ArticleId>
            <ArticleId IdType="pubmed">18791643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cailotto C
et al. (2008) Daily rhythms in metabolic liver enzymes and plasma glucose require a balance in the autonomic output to the liver. Endocrinology
149, 1914–1925</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18162516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herrera-Moro Chao D
et al. (2016) The Suprachiasmatic Nucleus Modulates the Sensitivity of Arcuate Nucleus to Hypoglycemia in the Male Rat. Endocrinology
157, 3439–3451</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27429160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodríguez-Cortés B
et al. (2022) Suprachiasmatic nucleus-mediated glucose entry into the arcuate nucleus determines the daily rhythm in blood glycemia. Curr. Biol. CB
32, 796–805.e4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">35030330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gubin DG
et al. (2017) Disrupted circadian rhythms of body temperature, heart rate and fasting blood glucose in prediabetes and type 2 diabetes mellitus. Chronobiol. Int
34, 1136–1148</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28759269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hogenboom R
et al. (2019) Loss of arginine vasopressin- and vasoactive intestinal polypeptide-containing neurons and glial cells in the suprachiasmatic nucleus of individuals with type 2 diabetes. Diabetologia
62, 2088–2093</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6805798</ArticleId>
            <ArticleId IdType="pubmed">31327049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saad A
et al. (2012) Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes
61, 2691–2700</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3478548</ArticleId>
            <ArticleId IdType="pubmed">22751690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morris CJ
et al. (2015) Endogenous circadian system and circadian misalignment impact glucose tolerance via separate mechanisms in humans. Proc. Natl. Acad. Sci
112, E2225–E2234</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4418873</ArticleId>
            <ArticleId IdType="pubmed">25870289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leung GKW
et al. (2017) Effect of meal timing on postprandial glucose responses to a low glycemic index meal: A crossover trial in healthy volunteers. Clin. Nutr. Edinb. Scotl DOI: 10.1016/j.clnu.2017.11.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clnu.2017.11.010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takahashi M
et al. (2018) Effects of Meal Timing on Postprandial Glucose Metabolism and Blood Metabolites in Healthy Adults. Nutrients
10, E1763.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6266071</ArticleId>
            <ArticleId IdType="pubmed">30441841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davis R
et al. (2020) Glycaemic response at night is improved after eating a high protein meal compared with a standard meal: A cross-over study. Clin. Nutr. Edinb. Scotl
39, 1510–1516</Citation>
        </Reference>
        <Reference>
          <Citation>Schulz B
et al. (1983) Diurnal rhythm of insulin sensitivity in subjects with normal and impaired glucose tolerance. Exp. Clin. Endocrinol
81, 263–272</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6350027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu MS
et al. (1986) Diurnal variation of insulin clearance and sensitivity in normal man. Proc. Natl. Sci. Counc. Repub. China B
10, 64–69</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3520622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>la Fleur SE
et al. (2001) A daily rhythm in glucose tolerance: a role for the suprachiasmatic nucleus. Diabetes
50, 1237–1243</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11375322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi S
et al. (2013) Circadian disruption leads to insulin resistance and obesity. Curr. Biol. CB
23, 372–381</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3595381</ArticleId>
            <ArticleId IdType="pubmed">23434278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coomans CP
et al. (2013) Detrimental effects of constant light exposure and high-fat diet on circadian energy metabolism and insulin sensitivity. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol
27, 1721–1732</Citation>
        </Reference>
        <Reference>
          <Citation>Coomans CP
et al. (2013) The suprachiasmatic nucleus controls circadian energy metabolism and hepatic insulin sensitivity. Diabetes
62, 1102–1108</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3609590</ArticleId>
            <ArticleId IdType="pubmed">23274903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Udoh US
et al. (2018) Genetic deletion of the circadian clock transcription factor BMAL1 and chronic alcohol consumption differentially alter hepatic glycogen in mice. Am. J. Physiol. Gastrointest. Liver Physiol
314, G431–G447</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5899240</ArticleId>
            <ArticleId IdType="pubmed">29191941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adlanmerini M
et al. (2021) REV-ERB nuclear receptors in the suprachiasmatic nucleus control circadian period and restrict diet-induced obesity. Sci. Adv
7, eabh2007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8550249</ArticleId>
            <ArticleId IdType="pubmed">34705514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee A
et al. (1992) Diurnal variation in glucose tolerance. Cyclic suppression of insulin action and insulin secretion in normal-weight, but not obese, subjects. Diabetes
41, 750–759</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1587401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peter R
et al. (2010) Daytime variability of postprandial glucose tolerance and pancreatic B-cell function using 12-h profiles in persons with Type 2 diabetes. Diabet. Med. J. Br. Diabet. Assoc
27, 266–273</Citation>
        </Reference>
        <Reference>
          <Citation>Sonnier T
et al. (2014) Glycemic control is impaired in the evening in prediabetes through multiple diurnal rhythms. J. Diabetes Complications
28, 836–843</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24835190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buijs RM
et al. (1999) Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway. Eur. J. Neurosci
11, 1535–1544</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10215906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li M-D
et al. (2021) Circadian Clock-Controlled Checkpoints in the Pathogenesis of Complex Disease. Front. Genet
12, 721231.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8452875</ArticleId>
            <ArticleId IdType="pubmed">34557221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oster H
et al. (2017) The Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids. Endocr. Rev
38, 3–45</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5563520</ArticleId>
            <ArticleId IdType="pubmed">27749086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suh S and Park MK (2017) Glucocorticoid-Induced Diabetes Mellitus: An Important but Overlooked Problem. Endocrinol. Metab. Seoul Korea
32, 180–189</Citation>
        </Reference>
        <Reference>
          <Citation>Arshad MF and Debono M (2021) Current and future treatment options for adrenal insufficiency. Curr. Opin. Endocrinol. Diabetes Obes
28, 303–311</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33782339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bright GM
et al. (1980) Failure of cortisol blockade to inhibit early morning increases in basal insulin requirements in fasting insulin-dependent diabetics. Diabetes
29, 662–664</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7002678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seshadri N and Doucette CA (2021) Circadian Regulation of the Pancreatic Beta Cell. Endocrinology
162, bqab089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8312638</ArticleId>
            <ArticleId IdType="pubmed">33914056</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perelis M
et al. (2015) Pancreatic β cell enhancers regulate rhythmic transcription of genes controlling insulin secretion. Science
350, aac4250.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4669216</ArticleId>
            <ArticleId IdType="pubmed">26542580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rakshit K and Matveyenko AV (2021) Induction of Core Circadian Clock Transcription Factor Bmal1 Enhances β-Cell Function and Protects Against Obesity-Induced Glucose Intolerance. Diabetes
70, 143–154</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7881843</ArticleId>
            <ArticleId IdType="pubmed">33087455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petrenko V
et al. (2017) Pancreatic α- and β-cellular clocks have distinct molecular properties and impact on islet hormone secretion and gene expression. Genes Dev. 31, 383–398</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5358758</ArticleId>
            <ArticleId IdType="pubmed">28275001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Papazoglou I
et al. (2022) A distinct hypothalamus-to-β cell circuit modulates insulin secretion. Cell Metab. 34, 285–298.e7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8935365</ArticleId>
            <ArticleId IdType="pubmed">35108515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakata M
et al. (2021) Circadian Clock Component BMAL1 in the Paraventricular Nucleus Regulates Glucose Metabolism. Nutrients
13, 4487.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8707417</ArticleId>
            <ArticleId IdType="pubmed">34960038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ikegami K
et al. (2019) Interconnection between circadian clocks and thyroid function. Nat. Rev. Endocrinol
15, 590–600</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7288350</ArticleId>
            <ArticleId IdType="pubmed">31406343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mullur R
et al. (2014) Thyroid Hormone Regulation of Metabolism. Physiol. Rev
94, 355–382</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4044302</ArticleId>
            <ArticleId IdType="pubmed">24692351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Philippe J and Dibner C (2015) Thyroid Circadian Timing: Roles in Physiology and Thyroid Malignancies. J. Biol. Rhythms
30, 76–83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25411240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mazzoccoli G
et al. (2004) The hypothalamic-pituitary-thyroid axis and melatonin in humans: Possible interactions in the control of body temperature. Neuro Endocrinol. Lett
25, 368–72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15580172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roelfsema F
et al. (2014) Thyrotropin Secretion in Healthy Subjects Is Robust and Independent of Age and Gender, and Only Weakly Dependent on Body Mass Index. J. Clin. Endocrinol. Metab
99, 570–578</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24276453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Russell W
et al. (2008) Free Triiodothyronine Has a Distinct Circadian Rhythm That Is Delayed but Parallels Thyrotropin Levels. J. Clin. Endocrinol. Metab
93, 2300–2306</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18364382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fahrenkrug J
et al. (2017) Hypophysectomy abolishes rhythms in rat thyroid hormones but not in the thyroid clock. J. Endocrinol
233, 209–216</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5446591</ArticleId>
            <ArticleId IdType="pubmed">28348112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aninye IO
et al. (2014) Circadian regulation of Tshb gene expression by Rev-Erbα (NR1D1) and nuclear corepressor 1 (NCOR1). J. Biol. Chem
289, 17070–17077</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4059148</ArticleId>
            <ArticleId IdType="pubmed">24794873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hage M
et al. (2011) Thyroid Disorders and Diabetes Mellitus. J. Thyroid Res
2011,</Citation>
        </Reference>
        <Reference>
          <Citation>Gao G
et al. (2019) Glycemic variation in uncontrolled Graves’ disease patients with normal glucose metabolism: Assessment by continuous glucose monitoring. Endocrine
64, 265–270</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6531392</ArticleId>
            <ArticleId IdType="pubmed">30515677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Torimoto K
et al. (2014) Glucose variability before and after treatment of a patient with Graves’ disease complicated by diabetes mellitus: assessment by continuous glucose monitoring. Endocr. J
61, 321–328</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24420389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tordjman S
et al. (2017) Melatonin: Pharmacology, Functions and Therapeutic Benefits. Curr. Neuropharmacol
15, 434–443</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5405617</ArticleId>
            <ArticleId IdType="pubmed">28503116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cipolla-Neto J and Amaral F.G. do (2018) Melatonin as a Hormone: New Physiological and Clinical Insights. Endocr. Rev
39, 990–1028</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30215696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maronde E and Stehle JH (2007) The mammalian pineal gland: known facts, unknown facets. Trends Endocrinol. Metab. TEM
18, 142–149</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17374488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karamitri A and Jockers R (2019) Melatonin in type 2 diabetes mellitus and obesity. Nat. Rev. Endocrinol
15, 105–125</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30531911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>la Fleur SE
et al. (2001) Role for the pineal and melatonin in glucose homeostasis: pinealectomy increases night-time glucose concentrations. J. Neuroendocrinol
13, 1025–1032</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11722698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kennaway DJ (2019) Melatonin research in mice: a review. Chronobiol. Int
36, 1167–1183</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31198062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Owino S
et al. (2016) Melatonin Signaling Controls the Daily Rhythm in Blood Glucose Levels Independent of Peripheral Clocks. PloS One
11, e0148214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4732609</ArticleId>
            <ArticleId IdType="pubmed">26824606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garaulet M
et al. (2020) Melatonin Effects on Glucose Metabolism: Time To Unlock the Controversy. Trends Endocrinol. Metab. TEM
31, 192–204</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7349733</ArticleId>
            <ArticleId IdType="pubmed">31901302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chieffi S
et al. (2017) Orexin System: The Key for a Healthy Life. Front. Physiol
8, 357.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5450021</ArticleId>
            <ArticleId IdType="pubmed">28620314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeitzer JM
et al. (2003) Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness. J. Neurosci. Off. J. Soc. Neurosci
23, 3555–3560</Citation>
        </Reference>
        <Reference>
          <Citation>Salomon RM
et al. (2003) Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol. Psychiatry
54, 96–104</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12873798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsuneki H
et al. (2016) Sleep Control, GPCRs, and Glucose Metabolism. Trends Endocrinol. Metab. TEM
27, 633–642</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27461005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsuneki H
et al. (2015) Hypothalamic orexin prevents hepatic insulin resistance via daily bidirectional regulation of autonomic nervous system in mice. Diabetes
64, 459–470</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25249578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yi C-X
et al. (2009) A major role for perifornical orexin neurons in the control of glucose metabolism in rats. Diabetes
58, 1998–2005</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2731521</ArticleId>
            <ArticleId IdType="pubmed">19592616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toi N
et al. (2019) Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitus. J. Clin. Transl. Endocrinol
15, 37–44</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6306692</ArticleId>
            <ArticleId IdType="pubmed">30619717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang L
et al. (2019) Rhythmic growth hormone secretion in physiological and pathological conditions: Lessons from rodent studies. Mol. Cell. Endocrinol
498, 110575.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31499134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang W
et al. (2021) The GH-IGF-1 Axis in Circadian Rhythm. Front. Mol. Neurosci
14, 742294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8458700</ArticleId>
            <ArticleId IdType="pubmed">34566581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vakili H
et al. (2016) Evidence for a Circadian Effect on the Reduction of Human Growth Hormone Gene Expression in Response to Excess Caloric Intake. J. Biol. Chem
291, 13823–13833</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4919464</ArticleId>
            <ArticleId IdType="pubmed">27151213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Müller EE
et al. (1999) Neuroendocrine Control of Growth Hormone Secretion. 79, 97</Citation>
        </Reference>
        <Reference>
          <Citation>Tan HY
et al. (2013) Hypothalamic Distribution of Somatostatin mRNA Expressing Neurones Relative to Pubertal and Adult Changes in Pulsatile Growth Hormone Secretion in Mice. J. Neuroendocrinol
25, 910–919</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23855876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vijayakumar A
et al. (2011) The Intricate Role of Growth Hormone in Metabolism. Front. Endocrinol
2,</Citation>
        </Reference>
        <Reference>
          <Citation>Shih K-C
et al. (2013) Effect of growth hormone on dawn phenomenon in patients with type 2 diabetes. Growth Factors Chur Switz. 31, 66–73</Citation>
        </Reference>
        <Reference>
          <Citation>Campbell PJ
et al. (1985) Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. N. Engl. J. Med
312, 1473–1479</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2859524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Navascues I
et al. (1988) Effect of a long-acting somatostatin derivative SMS 201–995 (sandostatin) on glucose homeostasis in type I diabetes mellitus. Horm. Res
29, 92–94</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2900205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perriello G
et al. (1990) Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia
33, 52–59</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2406181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnston DG
et al. (1986) Effects of SMS 201–995 on intermediary metabolism and endocrine status in normal and diabetic humans. Am. J. Med
81, 88–93</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2879452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davies RR
et al. (1989) Somatostatin analogues in diabetes mellitus. Diabet. Med. J. Br. Diabet. Assoc
6, 103–111</Citation>
        </Reference>
        <Reference>
          <Citation>Livingstone C (2013) Insulin-like growth factor-I (IGF-I) and clinical nutrition. Clin. Sci. Lond. Engl
1979
125, 265–280</Citation>
        </Reference>
        <Reference>
          <Citation>Liu Z
et al. (2016) Growth Hormone Control of Hepatic Lipid Metabolism. Diabetes
65, 3598–3609</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5127251</ArticleId>
            <ArticleId IdType="pubmed">27679560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bertani S
et al. (2010) Circadian Profile of Peripheral Hormone Levels in Sprague-Dawley Rats and in Common Marmosets (Callithrix jacchus). In Vivo
24, 827–836</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21164040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaudhari A
et al. (2017) Cryptochromes regulate IGF-1 production and signaling through control of JAK2-dependent STAT5B phosphorylation. Mol. Biol. Cell
28, 834–842</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5349790</ArticleId>
            <ArticleId IdType="pubmed">28100634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heuck C
et al. (1999) Circadian Variation in Serum Free Ultrafiltrable Insulin-Like Growth Factor I Concentrations in Healthy Children. Pediatr. Res
45, 733–736</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10231873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobayashi K
et al. (1997) Role of IGF Binding Protein- 1 in the Dawn Phenomenon and Glycemic Control in Children and Adolescents With IDDM. Diabetes Care
20, 1442–1447</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9283794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobayashi K
et al. (2000) A Role of Free Insulin-Like Growth Factor-I in Dawn Phenomenon in Children and Adolescents with TYPE 1 Diabetes Mellitus. Endocr. J
47, S91–S93</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10890193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ostrovski I
et al. (2020) Analysis of Prevalence, Magnitude and Timing of the Dawn Phenomenon in Adults and Adolescents With Type 1 Diabetes: Descriptive Analysis of 2 Insulin Pump Trials. Can. J. Diabetes
44, 229–235</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31630987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu W
et al. (2017) Self-Monitoring of Blood Glucose to Assess Dawn Phenomenon in Chinese People with Type 2 Diabetes Mellitus. Int. J. Endocrinol
2017, 1–7</Citation>
        </Reference>
        <Reference>
          <Citation>Monnier L
et al. (2012) Frequency and Severity of the Dawn Phenomenon in Type 2 Diabetes: Relationship to age. Diabetes Care
35, 2597–2599</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3507613</ArticleId>
            <ArticleId IdType="pubmed">22991448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bouchonville M
et al. (2014) The Effectiveness and Risks of Programming an Insulin Pump to Counteract the Dawn Phenomenon in Type 1 Diabetes. Endocr. Pract. Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol DOI: 10.4158/EP14198.OR</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4158/EP14198.OR</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35466006</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-108X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>45</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Trends in neurosciences</Title>
          <ISOAbbreviation>Trends Neurosci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Circadian clock, diurnal glucose metabolic rhythm, and dawn phenomenon.</ArticleTitle>
        <Pagination>
          <StartPage>471</StartPage>
          <EndPage>482</EndPage>
          <MedlinePgn>471-482</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tins.2022.03.010</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0166-2236(22)00061-3</ELocationID>
        <Abstract>
          <AbstractText>The circadian clock provides cue-independent anticipatory signals for diurnal rhythms of baseline glucose levels and glucose tolerance. The central circadian clock is located in the hypothalamic suprachiasmatic nucleus (SCN), which comprises primarily GABAergic neurons. The SCN clock regulates physiological diurnal rhythms of endogenous glucose production (EGP) and hepatic insulin sensitivity through neurohumoral mechanisms. Disruption of the molecular circadian clock is associated with the extended dawn phenomenon (DP) in type 2 diabetes (T2D), referring to hyperglycemia in the early morning without nocturnal hypoglycemia. The DP affects nearly half of patients with diabetes, with poorly defined etiology and a lack of targeted therapy. Here we review neural and secreted factors in physiological diurnal rhythms of glucose metabolism and their pathological implications for the DP.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Elsevier Ltd. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Peng</LastName>
            <ForeName>Fei</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Baylor College of Medicine, Houston, TX, USA; State Key Laboratory of Zoonotic Diseases, The First Hospital of Jilin University, Changchun, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Xin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiao</LastName>
            <ForeName>Fang</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Baylor College of Medicine, Houston, TX, USA; Department of Cadres Medical Care and Geriatrics, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Ruxing</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Zheng</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Baylor College of Medicine, Houston, TX, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA. Electronic address: zheng.sun@bcm.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>P30 ES030285</GrantID>
            <Acronym>ES</Acronym>
            <Agency>NIEHS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 ES027544</GrantID>
            <Acronym>ES</Acronym>
            <Agency>NIEHS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Trends Neurosci</MedlineTA>
        <NlmUniqueID>7808616</NlmUniqueID>
        <ISSNLinking>0166-2236</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>IY9XDZ35W2</RegistryNumber>
          <NameOfSubstance UI="D005947">Glucose</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D057906" MajorTopicYN="Y">Circadian Clocks</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002940" MajorTopicYN="N">Circadian Rhythm</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006943" MajorTopicYN="Y">Hyperglycemia</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013493" MajorTopicYN="N">Suprachiasmatic Nucleus</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">GABA</Keyword>
        <Keyword MajorTopicYN="N">SCN</Keyword>
        <Keyword MajorTopicYN="N">circadian rhythm</Keyword>
        <Keyword MajorTopicYN="N">diabetes</Keyword>
        <Keyword MajorTopicYN="N">metabolism</Keyword>
        <Keyword MajorTopicYN="N">neuron</Keyword>
      </KeywordList>
      <CoiStatement>Declaration of interests The authors declare no interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>6</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>25</Day>
          <Hour>5</Hour>
          <Minute>57</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35466006</ArticleId>
        <ArticleId IdType="mid">NIHMS1794598</ArticleId>
        <ArticleId IdType="pmc">PMC9117496</ArticleId>
        <ArticleId IdType="doi">10.1016/j.tins.2022.03.010</ArticleId>
        <ArticleId IdType="pii">S0166-2236(22)00061-3</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Takahashi JS (2017) Transcriptional architecture of the mammalian circadian clock. Nat. Rev. Genet
18, 164–179</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5501165</ArticleId>
            <ArticleId IdType="pubmed">27990019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patke A
et al. (2020) Molecular mechanisms and physiological importance of circadian rhythms. Nat. Rev. Mol. Cell Biol
21, 67–84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31768006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hastings MH
et al. (2018) Generation of circadian rhythms in the suprachiasmatic nucleus. Nat. Rev. Neurosci
19, 453–469</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29934559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colwell CS (2011) Linking neural activity and molecular oscillations in the SCN. Nat. Rev. Neurosci
12, 553–569</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4356239</ArticleId>
            <ArticleId IdType="pubmed">21886186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morin LP (2013) Neuroanatomy of the extended circadian rhythm system. Exp. Neurol
243, 4–20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3498572</ArticleId>
            <ArticleId IdType="pubmed">22766204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buijs RM (2013) The autonomic nervous system: a balancing act. Handb. Clin. Neurol
117, 1–11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24095111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okamura H (2007) Suprachiasmatic nucleus clock time in the mammalian circadian system. Cold Spring Harb. Symp. Quant. Biol
72, 551–556</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18419314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flaa A
et al. (2008) Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. Metabolism. 57, 1422–1427</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18803948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chazova I
et al. (2006) Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin. Diabetes Obes. Metab
8, 456–465</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16776753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klieverik LP
et al. (2008) Effects of thyrotoxicosis and selective hepatic autonomic denervation on hepatic glucose metabolism in rats. Am. J. Physiol. Endocrinol. Metab
294, E513–520</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18182466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smale L
et al. (2003) Mammalian diurnality: some facts and gaps. J. Biol. Rhythms
18, 356–366</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14582852</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmidt MI
et al. (1981) The dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variation. Diabetes Care
4, 579–585</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6751733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monnier L
et al. (2013) Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern?
Diabetes Care
36, 4057–4062</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3836163</ArticleId>
            <ArticleId IdType="pubmed">24170753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Neal TB and Luther EE (2020) Dawn Phenomenon. In StatPearls
StatPearls Publishing</Citation>
        </Reference>
        <Reference>
          <Citation>Porcellati F
et al. (2013) Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes. Diabetes Care
36, 3860–3862</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3836156</ArticleId>
            <ArticleId IdType="pubmed">24265365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li C
et al. (2020) The dawn phenomenon across the glycemic continuum: Implications for defining dysglycemia. Diabetes Res. Clin. Pract
166, 108308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32650035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carroll MF and Schade DS (2005) The dawn phenomenon revisited: implications for diabetes therapy. Endocr. Pract. Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol
11, 55–64</Citation>
        </Reference>
        <Reference>
          <Citation>Boden G
et al. (1996) Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production. Diabetes
45, 1044–1050</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8690150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Feo P
et al. (1986) Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon. Diabetologia
29, 475–480</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3530862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perriello G
et al. (1997) Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes
46, 1010–1016</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9166673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radziuk J and Pye S (2006) Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour?
Diabetologia
49, 1619–1628</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16752180</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding G
et al. (2021) REV-ERB in GABAergic neurons controls diurnal hepatic insulin sensitivity. Nature
592, 763–767</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8085086</ArticleId>
            <ArticleId IdType="pubmed">33762728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang Y
et al. (2017) Poor Sleep Quality Is Associated with Dawn Phenomenon and Impaired Circadian Clock Gene Expression in Subjects with Type 2 Diabetes Mellitus. Int. J. Endocrinol
2017, 4578973.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5352967</ArticleId>
            <ArticleId IdType="pubmed">28352282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren H
et al. (2015) [Association between sleep disorders and dawn phenomenon in patients with type 2 diabetes mellitus]. Zhonghua Yi Xue Za Zhi
95, 1209–1213</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26081502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chamorro R
et al. (2021) Acute mild dim light at night slightly modifies sleep but does not affect glucose homeostasis in healthy men. Sleep Med. 84, 158–164</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34153798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mokhlesi B
et al. (2017) Effect of one week of CPAP treatment of obstructive sleep apnoea on 24-hour profiles of glucose, insulin and counter-regulatory hormones in type 2 diabetes. Diabetes Obes. Metab
19, 452–456</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27860160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paing AC
et al. (2020) Diurnal patterns of objectively measured sedentary time and interruptions to sedentary time are associated with glycaemic indices in type 2 diabetes. J. Sci. Med. Sport
23, 1074–1079</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32646745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paing AC
et al. (2019) Dose-response between frequency of interruption of sedentary time and fasting glucose, the dawn phenomenon and night-time glucose in Type 2 diabetes. Diabet. Med. J. Br. Diabet. Assoc
36, 376–382</Citation>
        </Reference>
        <Reference>
          <Citation>Zheng X
et al. (2020) Effects of Exercise on Blood Glucose and Glycemic Variability in Type 2 Diabetic Patients with Dawn Phenomenon. BioMed Res. Int
2020, 6408724.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7057022</ArticleId>
            <ArticleId IdType="pubmed">32149118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalsbeek A
et al. (2014) Circadian control of glucose metabolism. Mol. Metab
3, 372–383</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4060304</ArticleId>
            <ArticleId IdType="pubmed">24944897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>La Fleur SE (2003) Daily rhythms in glucose metabolism: suprachiasmatic nucleus output to peripheral tissue. J. Neuroendocrinol
15, 315–322</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12588521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Cauter E
et al. (1997) Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr. Rev
18, 716–738</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9331550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>La Fleur SE
et al. (1999) A suprachiasmatic nucleus generated rhythm in basal glucose concentrations. J. Neuroendocrinol
11, 643–652</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10447803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Challet E
et al. (2004) Daily variations of blood glucose, acid-base state and PCO2 in rats: effect of light exposure. Neurosci. Lett
355, 131–135</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14729252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cailotto C
et al. (2005) The suprachiasmatic nucleus controls the daily variation of plasma glucose via the autonomic output to the liver: are the clock genes involved?
Eur. J. Neurosci
22, 2531–2540</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16307595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalsbeek A and Strubbe JH (1998) Circadian control of insulin secretion is independent of the temporal distribution of feeding. Physiol. Behav
63, 553–558</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9523898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bolli GB
et al. (1984) Demonstration of a dawn phenomenon in normal human volunteers. Diabetes
33, 1150–1153</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6389230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takeda Y
et al. (2014) Retinoic acid-related orphan receptor γ (RORγ): a novel participant in the diurnal regulation of hepatic gluconeogenesis and insulin sensitivity. PLoS Genet. 10, e1004331.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4022472</ArticleId>
            <ArticleId IdType="pubmed">24831725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iwayama K
et al. (2020) Diurnal variation in the glycogen content of the human liver using 13 C MRS. NMR Biomed. 33, e4289.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32157774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakagawa H and Okumura N (2010) Coordinated regulation of circadian rhythms and homeostasis by the suprachiasmatic nucleus. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci
86, 391–409</Citation>
        </Reference>
        <Reference>
          <Citation>Foppen E
et al. (2016) Suprachiasmatic Nucleus Neuropeptides and Their Control of Endogenous Glucose Production. J. Neuroendocrinol
28,</Citation>
        </Reference>
        <Reference>
          <Citation>Kalsbeek A
et al. (2004) Suprachiasmatic GABAergic inputs to the paraventricular nucleus control plasma glucose concentrations in the rat via sympathetic innervation of the liver. J. Neurosci. Off. J. Soc. Neurosci
24, 7604–7613</Citation>
        </Reference>
        <Reference>
          <Citation>Kalsbeek A
et al. (2008) Circadian control of the daily plasma glucose rhythm: an interplay of GABA and glutamate. PloS One
3, e3194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2527681</ArticleId>
            <ArticleId IdType="pubmed">18791643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cailotto C
et al. (2008) Daily rhythms in metabolic liver enzymes and plasma glucose require a balance in the autonomic output to the liver. Endocrinology
149, 1914–1925</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18162516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herrera-Moro Chao D
et al. (2016) The Suprachiasmatic Nucleus Modulates the Sensitivity of Arcuate Nucleus to Hypoglycemia in the Male Rat. Endocrinology
157, 3439–3451</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27429160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodríguez-Cortés B
et al. (2022) Suprachiasmatic nucleus-mediated glucose entry into the arcuate nucleus determines the daily rhythm in blood glycemia. Curr. Biol. CB
32, 796–805.e4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">35030330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gubin DG
et al. (2017) Disrupted circadian rhythms of body temperature, heart rate and fasting blood glucose in prediabetes and type 2 diabetes mellitus. Chronobiol. Int
34, 1136–1148</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28759269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hogenboom R
et al. (2019) Loss of arginine vasopressin- and vasoactive intestinal polypeptide-containing neurons and glial cells in the suprachiasmatic nucleus of individuals with type 2 diabetes. Diabetologia
62, 2088–2093</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6805798</ArticleId>
            <ArticleId IdType="pubmed">31327049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saad A
et al. (2012) Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes
61, 2691–2700</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3478548</ArticleId>
            <ArticleId IdType="pubmed">22751690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morris CJ
et al. (2015) Endogenous circadian system and circadian misalignment impact glucose tolerance via separate mechanisms in humans. Proc. Natl. Acad. Sci
112, E2225–E2234</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4418873</ArticleId>
            <ArticleId IdType="pubmed">25870289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leung GKW
et al. (2017) Effect of meal timing on postprandial glucose responses to a low glycemic index meal: A crossover trial in healthy volunteers. Clin. Nutr. Edinb. Scotl DOI: 10.1016/j.clnu.2017.11.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clnu.2017.11.010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takahashi M
et al. (2018) Effects of Meal Timing on Postprandial Glucose Metabolism and Blood Metabolites in Healthy Adults. Nutrients
10, E1763.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6266071</ArticleId>
            <ArticleId IdType="pubmed">30441841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davis R
et al. (2020) Glycaemic response at night is improved after eating a high protein meal compared with a standard meal: A cross-over study. Clin. Nutr. Edinb. Scotl
39, 1510–1516</Citation>
        </Reference>
        <Reference>
          <Citation>Schulz B
et al. (1983) Diurnal rhythm of insulin sensitivity in subjects with normal and impaired glucose tolerance. Exp. Clin. Endocrinol
81, 263–272</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6350027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu MS
et al. (1986) Diurnal variation of insulin clearance and sensitivity in normal man. Proc. Natl. Sci. Counc. Repub. China B
10, 64–69</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3520622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>la Fleur SE
et al. (2001) A daily rhythm in glucose tolerance: a role for the suprachiasmatic nucleus. Diabetes
50, 1237–1243</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11375322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi S
et al. (2013) Circadian disruption leads to insulin resistance and obesity. Curr. Biol. CB
23, 372–381</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3595381</ArticleId>
            <ArticleId IdType="pubmed">23434278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coomans CP
et al. (2013) Detrimental effects of constant light exposure and high-fat diet on circadian energy metabolism and insulin sensitivity. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol
27, 1721–1732</Citation>
        </Reference>
        <Reference>
          <Citation>Coomans CP
et al. (2013) The suprachiasmatic nucleus controls circadian energy metabolism and hepatic insulin sensitivity. Diabetes
62, 1102–1108</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3609590</ArticleId>
            <ArticleId IdType="pubmed">23274903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Udoh US
et al. (2018) Genetic deletion of the circadian clock transcription factor BMAL1 and chronic alcohol consumption differentially alter hepatic glycogen in mice. Am. J. Physiol. Gastrointest. Liver Physiol
314, G431–G447</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5899240</ArticleId>
            <ArticleId IdType="pubmed">29191941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adlanmerini M
et al. (2021) REV-ERB nuclear receptors in the suprachiasmatic nucleus control circadian period and restrict diet-induced obesity. Sci. Adv
7, eabh2007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8550249</ArticleId>
            <ArticleId IdType="pubmed">34705514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee A
et al. (1992) Diurnal variation in glucose tolerance. Cyclic suppression of insulin action and insulin secretion in normal-weight, but not obese, subjects. Diabetes
41, 750–759</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1587401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peter R
et al. (2010) Daytime variability of postprandial glucose tolerance and pancreatic B-cell function using 12-h profiles in persons with Type 2 diabetes. Diabet. Med. J. Br. Diabet. Assoc
27, 266–273</Citation>
        </Reference>
        <Reference>
          <Citation>Sonnier T
et al. (2014) Glycemic control is impaired in the evening in prediabetes through multiple diurnal rhythms. J. Diabetes Complications
28, 836–843</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24835190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buijs RM
et al. (1999) Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway. Eur. J. Neurosci
11, 1535–1544</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10215906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li M-D
et al. (2021) Circadian Clock-Controlled Checkpoints in the Pathogenesis of Complex Disease. Front. Genet
12, 721231.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8452875</ArticleId>
            <ArticleId IdType="pubmed">34557221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oster H
et al. (2017) The Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids. Endocr. Rev
38, 3–45</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5563520</ArticleId>
            <ArticleId IdType="pubmed">27749086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suh S and Park MK (2017) Glucocorticoid-Induced Diabetes Mellitus: An Important but Overlooked Problem. Endocrinol. Metab. Seoul Korea
32, 180–189</Citation>
        </Reference>
        <Reference>
          <Citation>Arshad MF and Debono M (2021) Current and future treatment options for adrenal insufficiency. Curr. Opin. Endocrinol. Diabetes Obes
28, 303–311</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33782339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bright GM
et al. (1980) Failure of cortisol blockade to inhibit early morning increases in basal insulin requirements in fasting insulin-dependent diabetics. Diabetes
29, 662–664</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7002678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seshadri N and Doucette CA (2021) Circadian Regulation of the Pancreatic Beta Cell. Endocrinology
162, bqab089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8312638</ArticleId>
            <ArticleId IdType="pubmed">33914056</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perelis M
et al. (2015) Pancreatic β cell enhancers regulate rhythmic transcription of genes controlling insulin secretion. Science
350, aac4250.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4669216</ArticleId>
            <ArticleId IdType="pubmed">26542580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rakshit K and Matveyenko AV (2021) Induction of Core Circadian Clock Transcription Factor Bmal1 Enhances β-Cell Function and Protects Against Obesity-Induced Glucose Intolerance. Diabetes
70, 143–154</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7881843</ArticleId>
            <ArticleId IdType="pubmed">33087455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petrenko V
et al. (2017) Pancreatic α- and β-cellular clocks have distinct molecular properties and impact on islet hormone secretion and gene expression. Genes Dev. 31, 383–398</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5358758</ArticleId>
            <ArticleId IdType="pubmed">28275001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Papazoglou I
et al. (2022) A distinct hypothalamus-to-β cell circuit modulates insulin secretion. Cell Metab. 34, 285–298.e7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8935365</ArticleId>
            <ArticleId IdType="pubmed">35108515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakata M
et al. (2021) Circadian Clock Component BMAL1 in the Paraventricular Nucleus Regulates Glucose Metabolism. Nutrients
13, 4487.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8707417</ArticleId>
            <ArticleId IdType="pubmed">34960038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ikegami K
et al. (2019) Interconnection between circadian clocks and thyroid function. Nat. Rev. Endocrinol
15, 590–600</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7288350</ArticleId>
            <ArticleId IdType="pubmed">31406343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mullur R
et al. (2014) Thyroid Hormone Regulation of Metabolism. Physiol. Rev
94, 355–382</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4044302</ArticleId>
            <ArticleId IdType="pubmed">24692351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Philippe J and Dibner C (2015) Thyroid Circadian Timing: Roles in Physiology and Thyroid Malignancies. J. Biol. Rhythms
30, 76–83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25411240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mazzoccoli G
et al. (2004) The hypothalamic-pituitary-thyroid axis and melatonin in humans: Possible interactions in the control of body temperature. Neuro Endocrinol. Lett
25, 368–72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15580172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roelfsema F
et al. (2014) Thyrotropin Secretion in Healthy Subjects Is Robust and Independent of Age and Gender, and Only Weakly Dependent on Body Mass Index. J. Clin. Endocrinol. Metab
99, 570–578</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24276453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Russell W
et al. (2008) Free Triiodothyronine Has a Distinct Circadian Rhythm That Is Delayed but Parallels Thyrotropin Levels. J. Clin. Endocrinol. Metab
93, 2300–2306</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18364382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fahrenkrug J
et al. (2017) Hypophysectomy abolishes rhythms in rat thyroid hormones but not in the thyroid clock. J. Endocrinol
233, 209–216</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5446591</ArticleId>
            <ArticleId IdType="pubmed">28348112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aninye IO
et al. (2014) Circadian regulation of Tshb gene expression by Rev-Erbα (NR1D1) and nuclear corepressor 1 (NCOR1). J. Biol. Chem
289, 17070–17077</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4059148</ArticleId>
            <ArticleId IdType="pubmed">24794873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hage M
et al. (2011) Thyroid Disorders and Diabetes Mellitus. J. Thyroid Res
2011,</Citation>
        </Reference>
        <Reference>
          <Citation>Gao G
et al. (2019) Glycemic variation in uncontrolled Graves’ disease patients with normal glucose metabolism: Assessment by continuous glucose monitoring. Endocrine
64, 265–270</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6531392</ArticleId>
            <ArticleId IdType="pubmed">30515677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Torimoto K
et al. (2014) Glucose variability before and after treatment of a patient with Graves’ disease complicated by diabetes mellitus: assessment by continuous glucose monitoring. Endocr. J
61, 321–328</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24420389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tordjman S
et al. (2017) Melatonin: Pharmacology, Functions and Therapeutic Benefits. Curr. Neuropharmacol
15, 434–443</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5405617</ArticleId>
            <ArticleId IdType="pubmed">28503116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cipolla-Neto J and Amaral F.G. do (2018) Melatonin as a Hormone: New Physiological and Clinical Insights. Endocr. Rev
39, 990–1028</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30215696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maronde E and Stehle JH (2007) The mammalian pineal gland: known facts, unknown facets. Trends Endocrinol. Metab. TEM
18, 142–149</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17374488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karamitri A and Jockers R (2019) Melatonin in type 2 diabetes mellitus and obesity. Nat. Rev. Endocrinol
15, 105–125</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30531911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>la Fleur SE
et al. (2001) Role for the pineal and melatonin in glucose homeostasis: pinealectomy increases night-time glucose concentrations. J. Neuroendocrinol
13, 1025–1032</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11722698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kennaway DJ (2019) Melatonin research in mice: a review. Chronobiol. Int
36, 1167–1183</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31198062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Owino S
et al. (2016) Melatonin Signaling Controls the Daily Rhythm in Blood Glucose Levels Independent of Peripheral Clocks. PloS One
11, e0148214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4732609</ArticleId>
            <ArticleId IdType="pubmed">26824606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garaulet M
et al. (2020) Melatonin Effects on Glucose Metabolism: Time To Unlock the Controversy. Trends Endocrinol. Metab. TEM
31, 192–204</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7349733</ArticleId>
            <ArticleId IdType="pubmed">31901302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chieffi S
et al. (2017) Orexin System: The Key for a Healthy Life. Front. Physiol
8, 357.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5450021</ArticleId>
            <ArticleId IdType="pubmed">28620314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeitzer JM
et al. (2003) Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness. J. Neurosci. Off. J. Soc. Neurosci
23, 3555–3560</Citation>
        </Reference>
        <Reference>
          <Citation>Salomon RM
et al. (2003) Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol. Psychiatry
54, 96–104</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12873798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsuneki H
et al. (2016) Sleep Control, GPCRs, and Glucose Metabolism. Trends Endocrinol. Metab. TEM
27, 633–642</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27461005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsuneki H
et al. (2015) Hypothalamic orexin prevents hepatic insulin resistance via daily bidirectional regulation of autonomic nervous system in mice. Diabetes
64, 459–470</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25249578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yi C-X
et al. (2009) A major role for perifornical orexin neurons in the control of glucose metabolism in rats. Diabetes
58, 1998–2005</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2731521</ArticleId>
            <ArticleId IdType="pubmed">19592616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toi N
et al. (2019) Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitus. J. Clin. Transl. Endocrinol
15, 37–44</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6306692</ArticleId>
            <ArticleId IdType="pubmed">30619717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang L
et al. (2019) Rhythmic growth hormone secretion in physiological and pathological conditions: Lessons from rodent studies. Mol. Cell. Endocrinol
498, 110575.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31499134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang W
et al. (2021) The GH-IGF-1 Axis in Circadian Rhythm. Front. Mol. Neurosci
14, 742294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8458700</ArticleId>
            <ArticleId IdType="pubmed">34566581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vakili H
et al. (2016) Evidence for a Circadian Effect on the Reduction of Human Growth Hormone Gene Expression in Response to Excess Caloric Intake. J. Biol. Chem
291, 13823–13833</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4919464</ArticleId>
            <ArticleId IdType="pubmed">27151213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Müller EE
et al. (1999) Neuroendocrine Control of Growth Hormone Secretion. 79, 97</Citation>
        </Reference>
        <Reference>
          <Citation>Tan HY
et al. (2013) Hypothalamic Distribution of Somatostatin mRNA Expressing Neurones Relative to Pubertal and Adult Changes in Pulsatile Growth Hormone Secretion in Mice. J. Neuroendocrinol
25, 910–919</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23855876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vijayakumar A
et al. (2011) The Intricate Role of Growth Hormone in Metabolism. Front. Endocrinol
2,</Citation>
        </Reference>
        <Reference>
          <Citation>Shih K-C
et al. (2013) Effect of growth hormone on dawn phenomenon in patients with type 2 diabetes. Growth Factors Chur Switz. 31, 66–73</Citation>
        </Reference>
        <Reference>
          <Citation>Campbell PJ
et al. (1985) Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. N. Engl. J. Med
312, 1473–1479</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2859524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Navascues I
et al. (1988) Effect of a long-acting somatostatin derivative SMS 201–995 (sandostatin) on glucose homeostasis in type I diabetes mellitus. Horm. Res
29, 92–94</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2900205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perriello G
et al. (1990) Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia
33, 52–59</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2406181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnston DG
et al. (1986) Effects of SMS 201–995 on intermediary metabolism and endocrine status in normal and diabetic humans. Am. J. Med
81, 88–93</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2879452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davies RR
et al. (1989) Somatostatin analogues in diabetes mellitus. Diabet. Med. J. Br. Diabet. Assoc
6, 103–111</Citation>
        </Reference>
        <Reference>
          <Citation>Livingstone C (2013) Insulin-like growth factor-I (IGF-I) and clinical nutrition. Clin. Sci. Lond. Engl
1979
125, 265–280</Citation>
        </Reference>
        <Reference>
          <Citation>Liu Z
et al. (2016) Growth Hormone Control of Hepatic Lipid Metabolism. Diabetes
65, 3598–3609</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5127251</ArticleId>
            <ArticleId IdType="pubmed">27679560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bertani S
et al. (2010) Circadian Profile of Peripheral Hormone Levels in Sprague-Dawley Rats and in Common Marmosets (Callithrix jacchus). In Vivo
24, 827–836</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21164040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaudhari A
et al. (2017) Cryptochromes regulate IGF-1 production and signaling through control of JAK2-dependent STAT5B phosphorylation. Mol. Biol. Cell
28, 834–842</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5349790</ArticleId>
            <ArticleId IdType="pubmed">28100634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heuck C
et al. (1999) Circadian Variation in Serum Free Ultrafiltrable Insulin-Like Growth Factor I Concentrations in Healthy Children. Pediatr. Res
45, 733–736</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10231873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobayashi K
et al. (1997) Role of IGF Binding Protein- 1 in the Dawn Phenomenon and Glycemic Control in Children and Adolescents With IDDM. Diabetes Care
20, 1442–1447</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9283794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobayashi K
et al. (2000) A Role of Free Insulin-Like Growth Factor-I in Dawn Phenomenon in Children and Adolescents with TYPE 1 Diabetes Mellitus. Endocr. J
47, S91–S93</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10890193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ostrovski I
et al. (2020) Analysis of Prevalence, Magnitude and Timing of the Dawn Phenomenon in Adults and Adolescents With Type 1 Diabetes: Descriptive Analysis of 2 Insulin Pump Trials. Can. J. Diabetes
44, 229–235</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31630987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu W
et al. (2017) Self-Monitoring of Blood Glucose to Assess Dawn Phenomenon in Chinese People with Type 2 Diabetes Mellitus. Int. J. Endocrinol
2017, 1–7</Citation>
        </Reference>
        <Reference>
          <Citation>Monnier L
et al. (2012) Frequency and Severity of the Dawn Phenomenon in Type 2 Diabetes: Relationship to age. Diabetes Care
35, 2597–2599</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3507613</ArticleId>
            <ArticleId IdType="pubmed">22991448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bouchonville M
et al. (2014) The Effectiveness and Risks of Programming an Insulin Pump to Counteract the Dawn Phenomenon in Type 1 Diabetes. Endocr. Pract. Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol DOI: 10.4158/EP14198.OR</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4158/EP14198.OR</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
